The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer

Recently, the preventive effect of Helicobacter pylori (Hp) eradication treatment on the incidence of gastric cancer has been reported. By Hp eradication treatment being performed for Hp-infected people in Iijima town, we will evaluate whether the incidence of gastric cancer and/or the medical care cost can be reduced as compared with those in the previous years.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Helicobacter Pylori Digestive System Diseases Digestive System Neoplasms Eradication Gastric Cancer Gastrointestinal Diseases Gastrointestinal Neoplasms Medical Care Cost Neoplasms Neoplasms by Site Stomach Diseases Stomach Neoplasms

Age range

19 year–69 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Showa Inan General hospital

Komagane, Nagano, 399-4191, Japan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

People who live in Iijima town at their age of 19 to 69 years

Treatment and study plan

Primary outcomes

the annual incidence of gastric cancer in Iijima town

Time frame: 10 years

Secondary outcomes

The annual medical care cost in Iijima town

Time frame: 10 years

Sponsors and collaborators

Lead sponsor

Showa Inan General Hospital

Other

Registry information

Official study title

The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town

Important dates

Study start: 2007
Primary completion: 2021
Study completion: 2021
First posted: Jan 17, 2008
Registry last updated: Feb 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed